Application of a single-objective, hybrid genetic algorithm approach to pharmacokinetic model building

Population Pharmacokinetic Modeling of Ziprasidone in Patients With Schizophrenia From the CATIE Study

(2011) Alette M. Wessels et al.   JOURNAL OF CLINICAL PHARMACOLOGY

Population Pharmacokinetics of Perphenazine in Schizophrenia Patients From CATIE: Impact of Race and Smoking

(2009) Yuyan Jin et al.   JOURNAL OF CLINICAL PHARMACOLOGY

Effect of Age, Weight, and CYP2C19 Genotype on Escitalopram Exposure

(2009) Yuyan Jin et al.   JOURNAL OF CLINICAL PHARMACOLOGY

Distilling Free-Form Natural Laws from Experimental Data

(2009) Michael Schmidt et al.   SCIENCE

An optimized ibuprofen dosing scheme for preterm neonates with patent ductus arteriosus, based on a population pharmacokinetic and pharmacodynamic study

(2008) Déborah Hirt et al.   BRITISH JOURNAL OF CLINICAL PHARMACOLOGY

Addressing the challenges of a cross-national investigation: lessons from the Pittsburgh-Pisa study of treatment-relevant phenotypes of unipolar depression

(2008) Ellen Frank et al.   Clinical Trials

Sex, Race, and Smoking Impact Olanzapine Exposure

(2008) Kristin L. Bigos et al.   JOURNAL OF CLINICAL PHARMACOLOGY